Cargando…

Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 pandemic in Japan

AIMS/INTRODUCTION: This study aimed to reveal lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 (COVID‐19) pandemic in Japan. MATERIALS AND METHODS: We retrospectively analyzed 1,402 outpatients with diabetes at a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahara, Mitsuyoshi, Watanabe, Hirotaka, Shiraiwa, Toshihiko, Maeno, Yoshifumi, Yamamoto, Kaoru, Shiraiwa, Yuka, Yoshida, Yoko, Nishioka, Norio, Katakami, Naoto, Shimomura, Iichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250997/ https://www.ncbi.nlm.nih.gov/pubmed/33768726 http://dx.doi.org/10.1111/jdi.13555

Ejemplares similares

Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Screening for a Decreased Masticatory Function by a Color-changeable Chewing Gum Test in Patients with Metabolic Disease
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)

Association between History of Vaccination and Symptoms at Diagnosis of Coronavirus Disease 2019
por: Shiraiwa, Toshihiko, et al.
Publicado: (2023)

Efficacy of liraglutide therapy in Japanese type 2 diabetic patients insufficiently controlled with basal‐supported oral therapy
por: Takahara, Mitsuyoshi, et al.
Publicado: (2012)

Patient Perspectives on Combination Therapy of a Once-weekly Oral Medication Plus Daily Medication for Lifestyle-related Chronic Diseases
por: Takahara, Mitsuyoshi, et al.
Publicado: (2017)

Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis
por: Mita, Tomoya, et al.
Publicado: (2017)

The Effect of Sitagliptin on the Regression of Carotid Intima-Media Thickening in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation
por: Mita, Tomoya, et al.
Publicado: (2017)

Changes in carotid intima‐media thickening in patients with type 2 diabetes mellitus: Subanalysis of the Sitagliptin Preventive Study of Intima‐Media Thickness Evaluation
por: Mita, Tomoya, et al.
Publicado: (2017)

Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER
por: Takahara, Mitsuyoshi, et al.
Publicado: (2021)

Changes of HbA1c variability after the switch to a longer‐acting insulin analog in people with type 1 diabetes
por: Watanabe, Hirotaka, et al.
Publicado: (2022)

The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis
por: Mita, Tomoya, et al.
Publicado: (2017)

Regular insulin, rather than rapid‐acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus
por: Kuroda, Akio, et al.
Publicado: (2013)

Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan—A Protocol
por: Katakami, Naoto, et al.
Publicado: (2017)

The Influence of Glycemic Control on the Prognosis of Japanese Patients Undergoing Percutaneous Transluminal Angioplasty for Critical Limb Ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2010)

Improved treatment satisfaction and medication adherence after readjusting oral medication regimens with the cooperation of health insurance pharmacy in type 2 diabetic patients in Japan
por: Ogawa, Naoko, et al.
Publicado: (2017)

Preoperative fundus examination in patients with diabetes scheduled for surgery
por: Watanabe, Hirotaka, et al.
Publicado: (2021)

Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study
por: Katakami, Naoto, et al.
Publicado: (2020)

Risk categorization for calculating net reclassification improvement
por: Takahara, Mitsuyoshi, et al.
Publicado: (2013)

Acute effects of whole body vibration exercise on post-load glucose metabolism in healthy men: a pilot randomized crossover trial
por: Watanabe, Hirotaka, et al.
Publicado: (2021)

Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial
por: Irie, Yoko, et al.
Publicado: (2018)

Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE)
por: Katakami, Naoto, et al.
Publicado: (2018)

Distribution of the Matsuda Index in Japanese healthy subjects
por: Takahara, Mitsuyoshi, et al.
Publicado: (2013)

Trends in maternal characteristics and perinatal outcomes among Japanese pregnant women with type 1 and type 2 diabetes from 1982 to 2020
por: Fujikawa Shingu, Kei, et al.
Publicado: (2022)

Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus
por: Mita, Tomoya, et al.
Publicado: (2017)

Clinical Utility of Carotid Ultrasonography in the Prediction of Cardiovascular Events in Patients with Diabetes: A Combined Analysis of Data Obtained in Five Longitudinal Studies
por: Katakami, Naoto, et al.
Publicado: (2018)

Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes
por: Mita, Tomoya, et al.
Publicado: (2019)

Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
por: Wakasugi, Satomi, et al.
Publicado: (2021)

Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2013)

Changes in Treatment Satisfaction Over 3 Years in Patients With Type 2 Diabetes After Initiating Second-line Treatment
por: Mita, Tomoya, et al.
Publicado: (2022)

Association of Diabetes and Hemodialysis With Ankle Pressure and Ankle-Brachial Index in Japanese Patients With Critical Limb Ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2012)

Assessment of vibratory sensation with a tuning fork at different sites in Japanese patients with diabetes mellitus
por: Takahara, Mitsuyoshi, et al.
Publicado: (2014)

Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients
por: Katakami, Naoto, et al.
Publicado: (2014)

Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
por: Mita, Tomoya, et al.
Publicado: (2017)

Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes
por: Mita, Tomoya, et al.
Publicado: (2023)

Laughter yoga as an enjoyable therapeutic approach for glycemic control in individuals with type 2 diabetes: A randomized controlled trial
por: Hirosaki, Mayumi, et al.
Publicado: (2023)

Dysregulated plasma glucagon levels in Japanese young adult type 1 diabetes patients
por: Kawamori, Dan, et al.
Publicado: (2018)

Consistency of plasma glucagon levels in patients with type 1 diabetes after a 1‐year period
por: Kawamori, Dan, et al.
Publicado: (2019)

The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control
por: Yoshii, Hidenori, et al.
Publicado: (2022)

Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139–148
por: Mita, Tomoya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dsctjv6lh1s6p9ik17ekbd434g